Pay in 4 interest-free payments of $5.33 Learn more
Ships within 48 hours · Estimated delivery Sep 8 - Sep 13
The April 2026 FDA action removes them from the Category 2 restricted compounding list effective April 23, 2026, and the FDAs Pharmacy Compounding Advisory Committee will review their compounding eligibility under 503A at its July 23-24, 2026 meeting
+ A highly bioavailable source of glutathione, our bodys most protective molecule
Experience the synergy of key nutrients working together to optimize your health
Magistretti PJ et al
The amplification of MCT1 and MCT4 has been demonstrated in solid tumors and represents a dominant force controlling glycolytic activities [54]
US$ 21.68
US$ 24.01
US$ 23.15
US$ 28.56
